Literature DB >> 6837793

Withdrawal symptoms after long-term treatment with therapeutic doses of flurazepam: a case report.

R M Berlin, L J Conell.   

Abstract

A male patient with chronic insomnia experienced withdrawal symptoms when flurazepam (30 mg h.s.), which he had taken nightly for 8 years, was abruptly discontinued. Problems associated with sedative-hypnotic medication and the long-term treatment of chronic insomnia are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837793     DOI: 10.1176/ajp.140.4.488

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  1 in total

Review 1.  Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.

Authors:  S I Ankier; K L Goa
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.